Fate Therapeutics Inc (FATE)

SG&A Expense Growth

-48.67%

Fiscal year · Period ending:

FATE logo

FATE SG&A Expense Growth

Latest reported-48.67%
FATE FY SG&A Growth (YoY) (0.00% → -48.67%)
High-resolution chart · PNG

FATE sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
-48.6744%
-6.4198%
14.9884%
46.9479%
69.1084%
43.4023%
49.5256%
33.1424%
19.772%
-4.2407%
22.234%
27.5644%
57.0246%
-8.1868%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.